Ab&b Bio-tech Co., Ltd.js
Clinical trials sponsored by Ab&b Bio-tech Co., Ltd.js, explained in plain language.
-
New flu shot for toddlers shows promise in major trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new four-strain flu vaccine in very young children to see if it is safe and if it triggers a strong immune response. It involved 2,772 healthy children aged 6 to 35 months, who received two doses of either the new vaccine or a control vaccine. Researchers clos…
Phase: PHASE3 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
Massive study tracks flu shot safety in over 40,000 people
⭐️ VACCINE ⭐️ CompletedThis study checked how safe a widely used flu vaccine is in a very large group of people. Over 42,000 participants, aged 3 and older, received the shot and were closely monitored for side effects for 28 days. The main goal was to look for any very rare safety issues that might no…
Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:39 UTC
-
First human test for new pneumonia shot shows promise
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested the safety and initial immune response of a new 23-valent pneumococcal vaccine designed to help prevent pneumonia. It involved 144 healthy volunteers, including children and adults, who received either the test vaccine or a control shot. Researchers …
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test new rabies shot schedules for safety
⭐️ VACCINE ⭐️ CompletedThis study tested the safety of a freeze-dried rabies vaccine when given to healthy people using two different dosing schedules. It involved 80 participants aged 10 to 60 years. The main goal was to check for side effects and monitor participants' health for six months after vacc…
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 06, 2026 15:38 UTC